Vor Biopharma (VOR) Other financing activities (2020 - 2026)
Vor Biopharma (VOR) posted quarterly Other financing activities of $75.0 million for Q1 2026, down 57.0% quarter-over-quarter from $174.4 million in Q2 2025.
Vor Biopharma (VOR) Other financing activities (2020 - 2026) Analysis & Trends
Vor Biopharma (VOR) has reported Other financing activities for 6 consecutive years, with $75.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Other financing activities changed N/A year-over-year to $75.0 million; the TTM figure through Mar 2026 stood at $249.4 million (up 1781321.43% YoY), while the FY2025 annual figure was $175.0 million, changed N/A from the prior year.
- Other financing activities retreated to $75.0 million in Q1 2026 per VOR's latest filing, from $174.4 million in the prior quarter.
- Across five years, Other financing activities topped out at $174.4 million in Q2 2025 and bottomed at $14000.0 in Q1 2023.
- Historically, Other financing activities has averaged $41.7 million across 4 years, with a median of $217000.0 in 2022.
- On a YoY basis, Other financing activities climbed as much as 100.12% in 2022 and fell as far as 99.89% in 2022.
- Vor Biopharma's Other financing activities stood at $234000.0 in 2022, then sank by 94.02% to $14000.0 in 2023, then surged by 1245614.29% to $174.4 million in 2025, then tumbled by 57.0% to $75.0 million in 2026.
- Business Quant data shows VOR's Other financing activities at $75.0 million in Q1 2026, $174.4 million in Q2 2025, and $14000.0 in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Vor Biopharma | 1.36 Bn | 1.36 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 75.00 Mn |
| Mar 31, 2026 | 75.00 Mn |
| Jun 30, 2025 | 174.40 Mn |
| Jun 30, 2025 | 174.40 Mn |
| Mar 31, 2023 | 14,000.00 |
| Mar 31, 2023 | 14,000.00 |
| Sep 30, 2022 | 234,000.00 |
| Sep 30, 2022 | 234,000.00 |
| Jun 30, 2022 | 100,000.00 |
| Jun 30, 2022 | 100,000.00 |
| Mar 31, 2022 | 200,000.00 |
| Mar 31, 2022 | 200,000.00 |
| Dec 31, 2021 | 188.95 Mn |
| Dec 31, 2021 | 188.95 Mn |
| Sep 30, 2021 | -188.95 Mn |
| Sep 30, 2021 | -188.95 Mn |
| Mar 31, 2021 | 189.20 Mn |
| Mar 31, 2021 | 189.20 Mn |
| Dec 31, 2020 | 46,000.00 |
| Dec 31, 2020 | 46,000.00 |